Polycyclo-carbocyclic Ring System Having At Least Three Cyclos Patents (Class 546/285)
  • Patent number: 10553797
    Abstract: An object is to provide a light-emitting element having high light-emission efficiency by provision of a novel fluorene derivative as represented by General Formula (G1) below. In the formula, R1 to R8 independently represent any of a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a substituted or unsubstituted phenyl group, or a substituted or unsubstituted biphenyl group. Further, ?1 to ?4 independently represent any of a substituted or unsubstituted arylene group having 6 to 12 carbon atoms. Furthermore, Ar1 and Ar2 independently represent any of an aryl group having 6 to 13 carbon atoms in a ring and Ar3 represents an alkyl group having 1 to 6 carbon atoms or a substituted or unsubstituted aryl group having 6 to 12 carbon atoms. J, k, m, and n each independently represent 0 or 1.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: February 4, 2020
    Assignee: Semiconductor Energy Laboratory Co., Ltd.
    Inventors: Harue Osaka, Satoko Shitagaki, Tsunenori Suzuki, Nobuharu Ohsawa, Sachiko Kawakami, Satoshi Seo
  • Patent number: 9149479
    Abstract: Compounds of the formula Ia***** in which the substituents have the definitions provided in the specification, are novel, effective PDE4 inhibitors, useful in the treatment of psoriasis.
    Type: Grant
    Filed: October 7, 2014
    Date of Patent: October 6, 2015
    Assignee: Takeda GmbH
    Inventor: Ulrich Kautz
  • Patent number: 9040567
    Abstract: The disclosure relates to BAX activators and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.
    Type: Grant
    Filed: August 17, 2012
    Date of Patent: May 26, 2015
    Assignees: Emory University, Board of Regents of the University of Texas System
    Inventors: Xingming Deng, Jia Zhou, Chunyong Ding
  • Patent number: 9035055
    Abstract: An organic compound and a photoelectric conversion device containing the organic compound are disclosed. The organic compound and device realize high photoelectric conversion efficiency, low dark current and high-speed responsivity. It has been found that when this organic compound and an n-type semiconductor are used in combination, high-speed responsivity can be realized while maintaining high heat resistance, an aspect of which has not been seen when the connection part between a donor part and an acceptor part is a phenylene group.
    Type: Grant
    Filed: September 8, 2010
    Date of Patent: May 19, 2015
    Assignee: FUJIFILM Corporation
    Inventors: Mitsumasa Hamano, Katsuyuki Yofu, Tetsuro Mitsui, Kimiatsu Nomura
  • Patent number: 9005778
    Abstract: There is provided a novel organic compound suitably used for a blue light-emitting device and an organic light-emitting device including the novel organic compound. The organic compound is an acephenanthryleno[4,5-k]benzo[e]acephenanthrylene derivative.
    Type: Grant
    Filed: April 19, 2011
    Date of Patent: April 14, 2015
    Assignee: Canon Kabushiki Kaisha
    Inventors: Tomonari Horikiri, Hiroyuki Tomono, Jun Kamatani
  • Patent number: 8975244
    Abstract: The present invention relates to a process for the synthesis of (3beta)17-(3-pyridinyl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) represented by the structure of formula (1), and salts thereof, especially salts with pharmaceutically acceptable acids. The present invention further relates to certain intermediates in such processes.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: March 10, 2015
    Assignee: Mapi Pharma Ltd.
    Inventors: Ehud Marom, Shai Rubnov, Michael Mizhiritskii
  • Patent number: 8968889
    Abstract: A novel organic compound suitable for emitting green light and an organic light-emitting device including the organic compound are provided. The organic compound is represented by general formula (1). In general formula (1), R1 to R18 are each independently selected from a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl group, a substituted or unsubstituted alkoxy group, a substituted amino group, a substituted or unsubstituted aryl group, and a substituted or unsubstituted heterocyclic group.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: March 3, 2015
    Assignee: Canon Kabushiki Kaisha
    Inventors: Jun Kamatani, Kengo Kishino, Naoki Yamada, Akihito Saitoh
  • Publication number: 20150041733
    Abstract: Optionally substituted 3-(10-(aryl)anthracen-9-yl)-5-(10-(aryl)anthracen-9-yl)pyridine compounds may be used as host compounds for devices such as organic light-emitting devices.
    Type: Application
    Filed: March 12, 2013
    Publication date: February 12, 2015
    Inventor: Shijun Zheng
  • Patent number: 8927549
    Abstract: Embodiments of the present invention provide adamantyl benzamide derivatives and pharmaceutical compositions comprising adamantyl benzamide derivatives. Methods of use of such compounds and compositions to modulate the activity of 11?-hydroxysteroid dehydrogenase type 1 (11?HSD1) in a subject are also provided.
    Type: Grant
    Filed: November 17, 2009
    Date of Patent: January 6, 2015
    Assignee: High Point Pharmaceuticals, LLC
    Inventors: Dharma Rao Polisetti, Suparna Gupta, Soren Ebdrup
  • Patent number: 8916275
    Abstract: Disclosed is an organic electroluminescent element which has achieved both high luminous efficiency and low driving voltage by containing a light-emitting element material, which comprises a specific pyrene compound, in one of the layers that constitute the light-emitting element, preferably in a light-emitting layer or in an electron-transporting layer.
    Type: Grant
    Filed: March 25, 2010
    Date of Patent: December 23, 2014
    Assignee: Toray Industries, Inc.
    Inventors: Yohei Nakano, Kazunori Sugimoto, Kazumasa Nagao, Daisaku Tanaka, Tsuyoshi Tominaga
  • Publication number: 20140353617
    Abstract: A condensed compound is represented by Formula 1 below: An organic light-emitting diode includes a substrate, a first electrode on the substrate, a second electrode disposed opposite to the first electrode, and an organic layer interposed between the first electrode and the second electrode. The organic layer includes at least one layer including a compound of Formula 1.
    Type: Application
    Filed: November 22, 2013
    Publication date: December 4, 2014
    Applicant: Samsung Display Co., Ltd.
    Inventors: Soo-Yon KIM, Seok-Hwan HWANG, Young-Kook KIM, Jun-Ha PARK, Hye-Jin JUNG, Eun-Young LEE, Sang-Hyun HAN, Jin-O LIM
  • Patent number: 8901310
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: December 2, 2014
    Assignee: Pfizer Inc.
    Inventors: Paul Vincent Rucker, Jeffery S. Snyder
  • Patent number: 8901155
    Abstract: A method for treating a TRPV1-mediated disease by administering to a patient a therapeutically effective amount of a compound or a salt thereof having the following formula [I]: wherein A represents a lower alkylene group or a lower alkenylene group; R1 represents a hydrogen atom, an unsubstituted or substituted alkyl group or an unsubstituted or substituted alkenyl group; and R2 and R3 are the same or different and represent a hydrogen atom, an unsubstituted lower alkyl group or a lower alkyl group substituted by a monocyclic cycloalkyl group, a polycyclic cycloalkyl group or an aryl group.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: December 2, 2014
    Assignee: Santen Pharmaceutical Co., Ltd.
    Inventors: Kenji Oki, Fumio Tsuji, Chikako Setoguchi, Iwao Seki, Masaaki Murai, Minoru Sasano
  • Publication number: 20140350032
    Abstract: The present invention relates to a compound characterized by the following Formula I: or a pharmaceutically acceptable salt thereof, wherein X, Y, and Z are as described herein. Compounds of the present invention are useful for the treatment of HIV.
    Type: Application
    Filed: December 14, 2012
    Publication date: November 27, 2014
    Inventors: Nianhe Han, Brian Alvin Johns, Jun Tang
  • Publication number: 20140343064
    Abstract: The present invention belongs to the field of natural medicine and pharmaceutical chemistry, and specifically relates to novel 2-substituted oleanolic acid derivatives of formula (I) or a pharmaceutically acceptable salt thereof, to a process for the preparation of these compounds, compositions containing such compounds and their use in preparing antineoplastic medicaments.
    Type: Application
    Filed: November 30, 2012
    Publication date: November 20, 2014
    Applicant: Hanghzhou Bensheng Pharmaceutical Co., Ltd
    Inventors: Rongzhen Xu, Frank Rong, Hongxi Lai, Fuwen Xie
  • Publication number: 20140343108
    Abstract: The present invention belongs to the field of natural medicine and pharmaceutical chemistry, and specifically relates to novel amidated derivatives of oleanolic acid according to formula (I) or a pharmaceutically acceptable salt thereof, to a process for the preparation of these compounds, compositions containing such compounds and their use in preparing antineoplastic medicaments.
    Type: Application
    Filed: November 30, 2012
    Publication date: November 20, 2014
    Inventors: Frank Rong, Rongzhen Xu, Fuwen Xie, Hongxi Lai
  • Publication number: 20140332772
    Abstract: A styryl-based compound represented by Formula 1 below is disclosed. An organic light-emitting diode including the styryl-based compound is also disclosed.
    Type: Application
    Filed: November 8, 2013
    Publication date: November 13, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Sang-Hyun Han, Seok-Hwan Hwang, Young-Kook Kim, Hye-Jin Jung, Jin-O Lim, Soo-Yon Kim, Eun-Jae Jeong, Jun-Ha Park, Eun-Young Lee, Jong-Hyuk Lee
  • Publication number: 20140336227
    Abstract: Compounds, pharmaceutical compositions of general formula (I) or (I?) or a pharmaceutically acceptable salt thereof, and methods for treating an inflammatory disorder: wherein: z is 1, 2 or 4; X is —CO—Yk—(R1)n; k is 0 or 1; Y is a cycloalkyl or polycycloalkyl, cycloalkenyl or polycycloalkenyl group; each R1 is a branched chain alkyl group; n is any integer from 1 to m, where m is the maximum number of substitutions permissible on the cyclo-group Y; and the compound comprises an amino lactam ring linked to an alkyl group —Yk—(R1)n by an amide group, wherein the carbon atom in the alkyl group at the 2-position relative to the carbon atom of the amide carbonyl is linked to each of the carbon atom of the amide carbonyl and three other carbon atoms by a single bond, and wherein the 2-position carbon atom has essentially tetrahedral bond angles.
    Type: Application
    Filed: November 4, 2013
    Publication date: November 13, 2014
    Applicant: CAMBRIDGE ENTERPRISE LIMITED
    Inventors: David J Grainger, David John Fox
  • Publication number: 20140316139
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: July 1, 2014
    Publication date: October 23, 2014
    Inventors: Paul Vincent RUCKER, Jeffery S. SNYDER
  • Publication number: 20140291653
    Abstract: An organic electroluminescence device which comprises a cathode, an anode and an organic thin film layer comprising at least one layer comprising a light emitting layer and disposed between the cathode and the anode, wherein at least one layer in the organic thin film layer comprises an anthracene derivative having a specific structure singly or as a component of a mixture, and an anthracene derivative having a specific asymmetric structure and providing an organic electroluminescence device exhibiting a great efficiency of light emission and having a long life, are provided.
    Type: Application
    Filed: June 11, 2014
    Publication date: October 2, 2014
    Applicant: IDEMITSU KOSAN CO., LTD.
    Inventors: Hidetsugu IKEDA, Motohisa IDO, Masakazu FUNAHASHI
  • Publication number: 20140264312
    Abstract: The present invention relates to a novel stable benzo[h]hexaphene compound and an organic light-emitting device including the compound. The present invention provides a benzo[h]hexaphene shown in Claim 1.
    Type: Application
    Filed: October 2, 2012
    Publication date: September 18, 2014
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Hirokazu Miyashita, Jun Kamatani, Tetsuya Kosuge, Akihito Saitoh
  • Patent number: 8822043
    Abstract: The present invention provides organic compounds which are indenobenzo[k]fluoranthene derivatives represented by the following general formula (1): In general formula (1), R1 to R14 are each independently selected from a hydrogen atom, a halogen atom, an alkyl group, an alkoxy group, an amino group, an aryl group, and a heterocyclic group.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: September 2, 2014
    Assignee: Canon Kabushiki Kaisha
    Inventors: Jun Kamatani, Naoki Yamada, Akihito Saitoh
  • Publication number: 20140241989
    Abstract: Compounds of formula (I) in which: >R is a linear or branched (C1-C6) alkyl, >L is a spacer group, >A is a diagnostic agent, and >m is equal to 1 or 2.
    Type: Application
    Filed: July 12, 2012
    Publication date: August 28, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS), LES LABORATOIRES SERVIER
    Inventors: Alain Lepape, Stéphanie Lerondel, Guillaume Reveillon, Jean-Marie Delbos, Luc Demuynck, Hubert Grandon, François Lefoulon, Gordon Tucker
  • Publication number: 20140209866
    Abstract: The present invention discloses a novel organic compound is represented by the following formula(A), the organic EL device employing the compound as blue emitting layer can lower driving voltage, prolong half-lifetime and increase the efficiency. Wherein m represent an integer of 0 to 8, n represent an integer of 0 to 10, p represent an integer of 0 to 7, HAr represent a hydrogen, a halide, a cyanine group, a substituted or unsusbstituted heteroaryl group system having 5 to 6 aromatic ring atoms, R1 to R4 are identical or different. R1 to R4 are independently selected from the group consisting of a hydrogen atom, alkyl group having 1 to 30 carbon atoms, a substituted or unsubstituted aryl group having 6 to 30 carbon atoms, a substituted or unsubstituted aralkyl group having 6 to 30 carbon atoms.
    Type: Application
    Filed: January 29, 2013
    Publication date: July 31, 2014
    Applicant: LUMINESCENCE TECHNOLOGY CORPORATION
    Inventor: LUMINESCENCE TECHNOLOGY CORPORATION
  • Publication number: 20140209872
    Abstract: A compound having an electron injection capability and/or electron transport capability represented by Formula 1, an organic light emitting device including the compound; and a flat display device including the organic light emitting device. The descriptions of substituents are referred to in the detailed description.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 31, 2014
    Inventors: Jun-Ha Park, Seok-Hwan Hwang, Young-Kook Kim, Hye-Jin Jung, Eun-Young Lee, Jin-O Lim, Sang-Hyun Han, Eun-Jae Jeong, Soo-Yon Kim, Jong-Hyuk Lee
  • Publication number: 20140197393
    Abstract: The present invention relates to a hydrocarbon-based fused ring compound and an organic light emitting device including the same.
    Type: Application
    Filed: December 20, 2013
    Publication date: July 17, 2014
    Applicant: HEESUNG MATERIAL LTD.
    Inventors: Jun-A LEE, Geon-Yu PARK, Jeong-Hoon YANG, Sung-Jin EUM, Joo-Dong LEE
  • Publication number: 20140194605
    Abstract: A SERS tag comprising a core comprising at least two aggregated particles of a SERS enhancing material wherein the contact point between the particles defines a crevice; and a reporter molecule having a length sufficiently short to fit into the crevice and a conjugated path length which is as large as possible, provided the overall reporter molecule length is maintained sufficiently short to fit into the crevice.
    Type: Application
    Filed: March 13, 2014
    Publication date: July 10, 2014
    Applicant: Cabot Security Materials, Inc.
    Inventors: Felicia Tam, Marcelo E. Piotti, Richard G. Freeman
  • Publication number: 20140183463
    Abstract: A condensed cyclic compound is represented by Formula 1, and an organic light-emitting device includes the condensed cyclic compound. The organic light-emitting device may include an organic layer containing the condensed-cyclic compound of Formula 1 and has low driving voltage, high emission efficiency, and long lifespan characteristics.
    Type: Application
    Filed: August 21, 2013
    Publication date: July 3, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Eun-Young Lee, Seok-Hwan Hwang, Young-Kook Kim, Hye-Jin Jung, Jun-Ha Park, Jin-O Lim, Sang-Hyun Han, Eun-Jae Jeong, Soo-Yon Kim, Jong-Hyuk Lee
  • Publication number: 20140178374
    Abstract: The disclosure relates to BAX activators and therapeutic uses relates thereto. In certain embodiments, the disclosure relates to methods of treating or preventing cancer, such as lung cancer, comprising administering a therapeutically effective amount of a pharmaceutical composition comprising a compound disclosed herein or pharmaceutically acceptable salt to a subject in need thereof.
    Type: Application
    Filed: August 17, 2012
    Publication date: June 26, 2014
    Applicants: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM, EMORY UNIVERSITY
    Inventors: Xingming Deng, Jia Zhou, Chunyong Ding
  • Publication number: 20140155357
    Abstract: The present invention pertains, at least in part, to novel substituted tetracycline compounds. These tetracycline compounds can be used to treat numerous tetracycline compound-responsive states, such as bacterial infections and neoplasms, as well as other known applications for tetracycline compounds such as blocking tetracycline efflux and modulation of gene expression.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 5, 2014
    Inventors: Paul Abato, Haregewein Assefa, Joel Berniac, Beena Bhatia, Todd Bowser, Jackson Chen, Mark Grier, Laura Honeyman, Mohamed Y. Ismail, Mark L. Nelson, Kwasi Ohemeng, Jingwen Pan
  • Publication number: 20140151670
    Abstract: An exemplary embodiment of the present application provides a new compound and an organic electronic device using the same. The organic electronic device according to an exemplary embodiment of the present application shows excellent characteristics in terms of efficiency, driving voltage, and service life.
    Type: Application
    Filed: July 19, 2013
    Publication date: June 5, 2014
    Applicant: LG CHEM, LTD.
    Inventors: Dong Hoon Lee, Minyoung Kang, Jungi Jang, Boonjae Jang, Minseung Chun, Kidong Koo
  • Publication number: 20140142316
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Application
    Filed: April 16, 2013
    Publication date: May 22, 2014
    Applicant: Pfizer Inc.
    Inventors: Hengmiao CHENG, Xiao HU, Kevin D. JEROME, Mark G. OBUKOWICZ, Lisa Maria OLSON, Paul V. RUCKER, Ronald Keith WEBBER
  • Publication number: 20140100227
    Abstract: Disclosed herein are novel C17-alkanediyl and alkenediyl derivatives of oleanolic acid, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds, for example, as antioxidant inflammation modulators, and compositions thereof are also provided.
    Type: Application
    Filed: September 10, 2013
    Publication date: April 10, 2014
    Applicant: REATA PHARMACEUTICALS, INC.
    Inventors: Christopher F. BENDER, Xin JIANG, Eric ANDERSON, Melean VISNICK
  • Patent number: 8680339
    Abstract: Compounds of Formula (I), wherein the substituents are as defined in claim 1, are suitable for use as herbicides.
    Type: Grant
    Filed: January 25, 2010
    Date of Patent: March 25, 2014
    Assignee: Syngenta Limited
    Inventors: Christopher John Mathews, John Finney, James Nicholas Scutt, Louisa Robinson, John Stephen Delaney
  • Publication number: 20140077175
    Abstract: A condensed-cyclic compound and an organic light-emitting diode including the condensed-cyclic compound.
    Type: Application
    Filed: March 13, 2013
    Publication date: March 20, 2014
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Hye-Jin Jung, Seok-Hwan Hwang, Young-Kook Kim, Jin-O Lim, Sang-Hyun Han, Eun-Jae Jeong, Soo-Yon Kim, Jun-Ha Park, Eun-Young Lee, Chang-Ho Lee, Jong-Hyuk Lee
  • Publication number: 20140061600
    Abstract: A pyrene compound and an organic light emitting diode device including the same are disclosed. The organic light emitting diode device includes at least two stacks provided between a first electrode and a second electrode, and a charge generation layer provided between the stacks and including an N type charge generation layer and a P type charge generation layer, wherein the N type charge generation layer is made of the pyrene compound.
    Type: Application
    Filed: December 21, 2012
    Publication date: March 6, 2014
    Applicant: LG DISPLAY CO., LTD.
    Inventors: Shinhan Kim, Jeongdae Seo, Hyoseok kim, Youngkwan Jung, Eunju Jeon
  • Publication number: 20140061601
    Abstract: An anthracene compound and organic light emitting diode including the same are disclosed. The organic light emitting diode includes, at least two stacks formed between a first electrode and a second electrode and a charge generation layer (CGL) including an N-type CGL and a P-type CGL formed between the stacks, wherein the N-type CGL is formed of the anthracene compound.
    Type: Application
    Filed: December 26, 2012
    Publication date: March 6, 2014
    Applicant: LG DISPLAY CO., LTD.
    Inventors: Hyoseok KIM, Jeongdae SEO, Eunju JEON, Shinhan KIM
  • Patent number: 8653275
    Abstract: Provided are bis-quaternary ammonium cyclophane compounds which are modulators of nicotinic acetylcholine receptors. Also provided are methods of using the compounds for modulating the function of a nicotinic acetylcholine receptor, and for the prevention and/or treatment of central nervous system disorders, substance use and/or abuse, and or gastrointestinal tract disorders.
    Type: Grant
    Filed: May 11, 2007
    Date of Patent: February 18, 2014
    Assignee: University of Kentucky Research Foundation
    Inventors: Peter Crooks, Linda P. Dwoskin, Guangrong Zheng, Sangeetha Sumithran, Davis D. Allen, Zhenfa Zheng, Paul Lockman
  • Publication number: 20140027754
    Abstract: The present invention provides a light emitting device material containing a compound having a specific pyrene structure, capable of providing an organic thin-film light emitting device which enables high-efficiency light emission and low-voltage driving, and is also excellent in durability; and a light emitting device using the same.
    Type: Application
    Filed: June 11, 2012
    Publication date: January 30, 2014
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Koji Ueoka, Kazumasa Nagao, Kazunori Sugimoto, Tsuyoshi Tominaga
  • Publication number: 20140014925
    Abstract: A compound represented by Formula 1 below and an organic light-emitting device including the compound are provided: Substituents in Formula 1 are the same as defined in the specification.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 16, 2014
    Inventors: Hye-Jin Jung, Seok-Hwan Hwang, Young-Kook Kim, Jin-O Lim, Sang-Hyun Han, Eun-Jae Jeong, Soo-Yon Kim, Jun-Ha Park, Eun-Young Lee, Chang-Ho Lee, Jong-Hyuk Lee
  • Publication number: 20130328021
    Abstract: Embodiments of the present disclosure are directed to a compound represented by Formula 1, and to organic light-emitting diodes including the compound.
    Type: Application
    Filed: November 13, 2012
    Publication date: December 12, 2013
    Applicant: SAMSUNG DISPLAY CO., LTD.
    Inventors: Jin-O Lim, Seok-Hwan Hwang, Young-Kook Kim, Hye-Jin Jung, Sang-Hyun Han, Soo-Yon Kim, Eun-Jae Jeong, Jun-Ha Park, Eun-Young Lee, Il-Soo Oh, Jong-Hyuk Lee
  • Publication number: 20130292662
    Abstract: The present invention provides an organic compound having a basic skeleton which has an emission wavelength in the yellow region, a high luminous efficiency, and good sublimability. An organic compound is shown in claim 1.
    Type: Application
    Filed: December 9, 2011
    Publication date: November 7, 2013
    Applicant: CANON KABUSHIKI KAISHA
    Inventors: Masashi Hashimoto, Jun Kamatani, Takayuki Horiuchi, Hirokazu Miyashita, Naoki Yamada, Akihito Saitoh
  • Publication number: 20130274240
    Abstract: The present invention provides an agent for the prophylactic or treatment of diabetes, diabetic complications, insulin resistance syndrome, metabolic syndrome, hyperglycemia, dyslipidemia, atherosclerosis, cardiac failure, cardiomyopathy, myocardial ischemia, brain ischemia, cerebral apoplexy, pulmonary hypertension, hyperlactacidemia, mitochondrial disease, mitochondrial encephalomyopathy or cancer, namely, a PDHK inhibitor and the like. A compound represented by the following formula [I] or a pharmaceutically acceptable salt thereof, or a solvate thereof: wherein each symbol is as defined in the specification.
    Type: Application
    Filed: November 5, 2012
    Publication date: October 17, 2013
    Inventor: JAPAN TOBACCO INC.
  • Patent number: 8552035
    Abstract: The present invention is directed to compounds of Formula I: or salt thereof, which are modulators of the glucocorticoid receptor. The compounds and salts of the invention are useful in the treatment of conditions mediated by glucocorticoid receptor activity.
    Type: Grant
    Filed: February 27, 2012
    Date of Patent: October 8, 2013
    Assignee: Pfizer Inc.
    Inventor: Paul V. Rucker
  • Publication number: 20130256645
    Abstract: A compound for an organic optoelectronic device, an organic light emitting diode including the same, and a display device including the organic light emitting diode are disclosed, the compound being represented by the following Chemical Formula 1:
    Type: Application
    Filed: June 3, 2013
    Publication date: October 3, 2013
    Inventors: Soo-Hyun MIN, Eun-Sun YU, Hyung-Sun KIM, Mi-Young CHAE
  • Patent number: 8546578
    Abstract: This disclosure relates to compounds, reagents, and methods useful in the synthesis of aryl fluorides, for example, in the preparation of 18F labeled radiotracers. For example, this disclosure provides universal “locked” aryl substituents that result in StereoElectronic Control of Unidirectional Reductive Elimination (SECURE) from diaryliodonium salts. The reagents and methods provided herein may be used to access a broad range of compounds, including aromatic compounds, heteroaromatic compounds, amino acids, nucleotides, and synthetic compounds.
    Type: Grant
    Filed: February 4, 2011
    Date of Patent: October 1, 2013
    Assignee: NUtech Ventures
    Inventor: Stephen DiMagno
  • Publication number: 20130252930
    Abstract: Provided herein are inhibitors of CYP11B, CYP17, and/or CYP21 enzymes of Formula (Z), (IX), (X), (XI), (XII), (XIII), (XIV), (XV), (XVI), or (XVII). Also described herein are pharmaceutical compositions that include at least one compound described herein and the use of a compound or pharmaceutical composition described herein to treat androgen-dependent diseases, disorders and conditions.
    Type: Application
    Filed: December 16, 2011
    Publication date: September 26, 2013
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Daniel Chu, Bing Wang, Tao Ye
  • Publication number: 20130234118
    Abstract: Embodiments of the present invention include an amine-based compound represented by Formula 1, an organic light-emitting diode including the amine-based compound, and an organic light-emitting apparatus including the amine-based compound.
    Type: Application
    Filed: December 5, 2012
    Publication date: September 12, 2013
    Applicant: SAMSUNG DISPLAY CO. LTD.
    Inventors: O-Hyun Kwon, Dong-Woo Shin, Kyul Han, Seul-Ong Kim, Byoung-Ki Choi
  • Patent number: 8530465
    Abstract: The invention provides a series of novel 1,2-disubstituted amido-anthraquinone derivatives. Further, the invention also provides the preparation method and application of said derivatives, said application comprises: said derivatives with therapeutically effective amount are prepared into pharmaceutical compositions for inhibition of cancer cell growth, further treating cancer.
    Type: Grant
    Filed: August 1, 2012
    Date of Patent: September 10, 2013
    Assignee: National Defense Medical Center
    Inventors: Hsu-Shan Huang, Chia-Chung Lee
  • Publication number: 20130221332
    Abstract: Novel compounds containing a triphenylene moiety linked to an ?? connected binaphthyl ring system are provided. These compounds have surprisingly good solubility in organic solvents and are useful as host compounds in red phosphorescent OLEDs.
    Type: Application
    Filed: December 18, 2012
    Publication date: August 29, 2013
    Applicant: Universal Display Corporation
    Inventor: Universal Display Corporation